Bio-responsive alginate-keratin composite nanogels with enhanced drug loading efficiency for cancer therapy
•We synthesized functional nanogels with high drug loading capacity.•These nanogels have around 80nm and enzyme-/GSH- responsive property.•DOX loaded nanogels showed excellent inhibitory effects on tumor cells in vitro.•DOX loaded nanogels had a better anti-tumor effect and lower side effects in viv...
Gespeichert in:
Veröffentlicht in: | Carbohydrate polymers 2017-11, Vol.175, p.159-169 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •We synthesized functional nanogels with high drug loading capacity.•These nanogels have around 80nm and enzyme-/GSH- responsive property.•DOX loaded nanogels showed excellent inhibitory effects on tumor cells in vitro.•DOX loaded nanogels had a better anti-tumor effect and lower side effects in vivo.
This article presents a novel dual-stimuli responsive nanogel prepared from human hair keratin and alginate through simple crosslinking method. Keratin offer the crosslinking structure and bio-responsive ability and alginate ameliorated properties of nanogels including particle size, stability and drug loading capacity. The resultant keratin-alginate nanogels (KSA-NGs) could function as promising vectors for doxorubicin hydrochloride (DOX) with a super-high drug-loading rate of 52.9% (w/w) and dual-stimuli responsive behavior to GSH and trypsin. Cellular uptake results indicated DOX loaded KSA-NGs (DOX@KSA-NGs) are efficiently internalized in 4T1 and B16 cells in vitro, with a fast DOX release into cells under intracellular GSH and trypsin levels. In vitro cytotoxicity results further manifested that DOX@KSA-NGs behaved equivalent inhibition effects on tumor cells to DOX. In vivo experiments showed that DOX@KSA-NGs had a better anti-tumor effect and lower side effects compared to free drugs. These bio-responsive KSA-NGs have potential applications as nanocarriers for cancer therapy. |
---|---|
ISSN: | 0144-8617 1879-1344 |
DOI: | 10.1016/j.carbpol.2017.07.078 |